FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000409924> ?p ?o ?g. }

• W3000409924 endingPage "17" @default.
• W3000409924 startingPage "11" @default.
• W3000409924 abstract "Background: The American Heart Association (2016) stated that at the age of forty the risk of developing heart failure is one in five. Medication is based on clinical signs and symptoms that are often late. Early cardiac markers are required to guide therapy. This study compared the difference between ST2 and NT-ProBNP concentrations before and after ACE inhibitors (ACE-I) in NYHA III-IV heart failure patients.Method: This was a randomized prospective observational study without controls. The respondents were males or females, 21-75 y.o in NYHA III-IV heart failure patients. Twenty-five respondents were appropriate to inclusion criteria. The ST2 was measured by Quantikine®ST2/IL-33R quantitative sandwich ELISA immunoassay while NT-proBNP was measured by Immulite Turbo® 1000.Result: Majority of respondents were males (60%) and had comorbidities(60,7%), consisting of NYHA Class III(36%) and IV(64%). Coronary artery disease and valvular heart disease (40%,36% respectively). Length of stay was 6.4±3.4days. The concentration difference of ST2 and NT-proBNP before and after ACE-I were both significant, however, NT-proBNP was more significant (p=0,001 vs p=0,023). NYHA at admission influenced ST2 difference but not NT-proBNP. NT-proBNP concentration correlated to length of stay while ST2 was not. ST2 had negative correlation with age, no correlation to GFR and weight. NT-proBNP was correlated to weight, negatively correlated to GFR, not correlated to age. ACE-I subtypes difference did not affect the study result.Conclusion: NT-proBNP was a better heart failure cardiac marker than ST2 due to its ability in diagnosis, prognosis and showing more significant difference after ACE-I administration." @default.
• W3000409924 created "2020-01-23" @default.
• W3000409924 creator A5011650468 @default.
• W3000409924 creator A5015234378 @default.
• W3000409924 creator A5057537219 @default.
• W3000409924 date "2019-11-22" @default.
• W3000409924 modified "2023-10-17" @default.
• W3000409924 title "Comparison of Concentration Difference between ST2 and NT-Pro BNP Before and After Ace-Inhibitors in NYHA III-IV Hearts Failure Patients" @default.
• W3000409924 cites W1976285945 @default.
• W3000409924 cites W1992026614 @default.
• W3000409924 cites W2004190980 @default.
• W3000409924 cites W2006109539 @default.
• W3000409924 cites W2007404307 @default.
• W3000409924 cites W2014573841 @default.
• W3000409924 cites W2017088015 @default.
• W3000409924 cites W2029419600 @default.
• W3000409924 cites W2060307528 @default.
• W3000409924 cites W2065184422 @default.
• W3000409924 cites W2070247508 @default.
• W3000409924 cites W2084656663 @default.
• W3000409924 cites W2093154042 @default.
• W3000409924 cites W2151562223 @default.
• W3000409924 cites W2189764970 @default.
• W3000409924 cites W2239703144 @default.
• W3000409924 cites W2260198442 @default.
• W3000409924 cites W2342331221 @default.
• W3000409924 cites W2427094903 @default.
• W3000409924 cites W2443131484 @default.
• W3000409924 cites W2559244213 @default.
• W3000409924 cites W2572817502 @default.
• W3000409924 cites W2583307872 @default.
• W3000409924 cites W2610602137 @default.
• W3000409924 cites W2735219142 @default.
• W3000409924 cites W2766427323 @default.
• W3000409924 cites W2773859502 @default.
• W3000409924 cites W2885546072 @default.
• W3000409924 cites W2891997425 @default.
• W3000409924 cites W4238907867 @default.
• W3000409924 doi "https://doi.org/10.24293/ijcpml.v26i1.1366" @default.
• W3000409924 hasPublicationYear "2019" @default.
• W3000409924 type Work @default.
• W3000409924 sameAs 3000409924 @default.
• W3000409924 citedByCount "2" @default.
• W3000409924 countsByYear W30004099242020 @default.
• W3000409924 countsByYear W30004099242022 @default.
• W3000409924 crossrefType "journal-article" @default.
• W3000409924 hasAuthorship W3000409924A5011650468 @default.
• W3000409924 hasAuthorship W3000409924A5015234378 @default.
• W3000409924 hasAuthorship W3000409924A5057537219 @default.
• W3000409924 hasBestOaLocation W30004099241 @default.
• W3000409924 hasConcept C126322002 @default.
• W3000409924 hasConcept C164705383 @default.
• W3000409924 hasConcept C23131810 @default.
• W3000409924 hasConcept C2778198053 @default.
• W3000409924 hasConcept C2778213512 @default.
• W3000409924 hasConcept C2779736815 @default.
• W3000409924 hasConcept C3018023364 @default.
• W3000409924 hasConcept C71924100 @default.
• W3000409924 hasConceptScore W3000409924C126322002 @default.
• W3000409924 hasConceptScore W3000409924C164705383 @default.
• W3000409924 hasConceptScore W3000409924C23131810 @default.
• W3000409924 hasConceptScore W3000409924C2778198053 @default.
• W3000409924 hasConceptScore W3000409924C2778213512 @default.
• W3000409924 hasConceptScore W3000409924C2779736815 @default.
• W3000409924 hasConceptScore W3000409924C3018023364 @default.
• W3000409924 hasConceptScore W3000409924C71924100 @default.
• W3000409924 hasIssue "1" @default.
• W3000409924 hasLocation W30004099241 @default.
• W3000409924 hasOpenAccess W3000409924 @default.
• W3000409924 hasPrimaryLocation W30004099241 @default.
• W3000409924 hasRelatedWork W1969060188 @default.
• W3000409924 hasRelatedWork W2043587455 @default.
• W3000409924 hasRelatedWork W2047359258 @default.
• W3000409924 hasRelatedWork W2058918176 @default.
• W3000409924 hasRelatedWork W2104371670 @default.
• W3000409924 hasRelatedWork W2125804349 @default.
• W3000409924 hasRelatedWork W2143993959 @default.
• W3000409924 hasRelatedWork W2270377498 @default.
• W3000409924 hasRelatedWork W2964563167 @default.
• W3000409924 hasRelatedWork W2979861098 @default.
• W3000409924 hasVolume "26" @default.
• W3000409924 isParatext "false" @default.
• W3000409924 isRetracted "false" @default.
• W3000409924 magId "3000409924" @default.
• W3000409924 workType "article" @default.